Proteomics International: Raises $6M for high-tech blood test

  • Proteomics International (PIQ) has received firm commitments to undertake a $6 million share placement
  • 12.5 million shares will issued to sophisticated and professional investors at 48 cents each
  • Additionally, the company will issue 2.2 million options to Euroz Hartleys Securities and Candour Advisory
  • These options will have an exercise price of 75 cents with expiry two years after issue
  • Proteomics will also use the funds to manufacture, market, and speed-up regulatory approvals for its PromarkerD test and strengthen its balance sheet
  • Proteomics is up 9 per cent on the market with shares trading for 60 cents each
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

Robinhood Launches $695 Annual Platinum Credit Card, Challenging Amex

The new offering aims to disrupt the premium credit card market.Highlights: Robinhood's new Platinum credit card costs $695...

Citi and HSBC Invest in Trading Tech Player Adaptive, Boosting Innovation

This investment aims to enhance financial trading technology solutions.Highlights: Citi and HSBC jointly invest in trading tech company...

NYSE Owner Strengthens Investment in Crypto Exchange OKX

Intercontinental Exchange enhances its portfolio with a significant move into cryptocurrency.Highlights: Intercontinental Exchange increases investment in crypto exchange...

Mastercard Launches Trust Layer for Agentic Commerce Transactions

New technology aims to enhance security and trust in digital commerce.Highlights: Mastercard's new Trust Layer aims to improve...